Farallon Capital Amends Enanta Pharma Stake (SC 13G/A)

TL;DR

**Farallon Capital just updated its Enanta Pharma stake, watch for market reaction.**

AI Summary

Farallon Capital Partners, L.P. filed an amended SC 13G/A on January 26, 2024, indicating a change in their ownership of Enanta Pharmaceuticals, Inc. common stock as of December 31, 2023. This filing, Amendment No. 5, updates their previous disclosures regarding their investment in the pharmaceutical company. This matters to investors because it signals a potential shift in a significant institutional investor's confidence or strategy regarding Enanta Pharmaceuticals, which could influence market perception and stock price.

Why It Matters

This filing shows an update to a major institutional investor's position in Enanta Pharmaceuticals, which can signal their changing sentiment about the company's future prospects.

Risk Assessment

Risk Level: medium — Changes in significant institutional ownership can introduce volatility and uncertainty for a stock, depending on the nature of the change.

Analyst Insight

Investors should monitor subsequent filings from Farallon Capital Partners, L.P. and Enanta Pharmaceuticals, Inc. to understand the specific changes in ownership and any potential strategic implications.

Key Players & Entities

• Farallon Capital Partners, L.P. (company) — the reporting person filing the SC 13G/A
• Enanta Pharmaceuticals, Inc. (company) — the issuer whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 26, 2024 (date) — the filing date of the SC 13G/A
• Amendment No. 5 (number) — the specific amendment number of the filing

FAQ

Key Financial Figures

• $0.01 — ame of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securitie

Filing Documents

• enta_13ga.htm (SC 13G/A) — 416KB
• 0000908834-24-000024.txt ( ) — 417KB

From the Filing

SC 13G/A 1 enta_13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5) * Enanta Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 29251M106 (Cusip Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) S Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) Page 1 of 34 Pages Exhibit Index Found on Page 33 13G CUSIP No. 29251M106 1 NAMES OF REPORTING PERSONS Farallon Capital Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 2,025,000 Shares, representing 9.6% of the class of securities. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION California NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 379,200 7 SOLE DISPOSITIVE POWER -0- 8 SHARED DISPOSITIVE POWER 379,200 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 379,200 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.8% 12 TYPE OF REPORTING PERSON (See Instructions) PN Page 2 of 34 Pages 13G CUSIP No. 29251M106 1 NAMES OF REPORTING PERSONS Farallon Capital Institutional Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 2,025,000 Shares, representing 9.6% of the class of securities. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION California NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 448,400 7 SOLE DISPOSITIVE POWER -0- 8 SHARED DISPOSITIVE POWER 448,400 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 448,400 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.1% 12 TYPE OF REPORTING PERSON (See Instructions) PN Page 3 of 34 Pages 13G CUSIP No. 29251M106 1 NAMES OF REPORTING PERSONS Farallon Capital Institutional Partners II, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 2,025,000 Shares, representing 9.6% of the class of securities. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION California NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 103,500 7 SOLE DISPOSITIVE POWER -0- 8 SHARED DISPOSITIVE POWER 103,500 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 103,500 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.5% 12 TYPE OF REPORTING PERSON (See Instructions) PN Page 4 of 34 Pages 13G CUSIP No. 29251M106 1 NAMES OF REPORTING PERSONS Farallon Capital Institutional Partners III, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 2,025,000 Shares, representing 9.6% of the class of securities. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 56,600 7 SOLE DISPOSITIVE POWER -0-

View Full Filing

View this SC 13G/A filing on SEC EDGAR